Marquet Magda

SEC CIK: 0001631486

SEC filings (opens in a new tab)

In the past year, 1 open-market sale filing worth $530.6K and no purchases.

Current role at each company

TRAX First Tracks Biotherapeutics, Inc.Directoras of Jun 17, 2026
ARCT Arcturus Therapeutics Holdings Inc.Directoras of Jun 15, 2026
IMMX Immix Biopharma, Inc.Directoras of May 29, 2026
ANAB Anaptysbio, IncDirectoras of Jan 16, 2026
RNAZ Transcode Therapeutics, Inc.Directoras of Jun 18, 2024

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $530.6K; 1 filing
Net: −$530.6K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Marquet Magda as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

ANAB Anaptysbio, Inc

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Jan 16, 2026 (view filing)	Jan 15	1 day	Marquet MagdaDirector	SSale	−11.0K	$48.23	−$530.6K	−52.6%9.93K after	2 lots

IMMX Immix Biopharma, Inc.

Director3 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change
Sep 8, 2023 (view filing)	Sep 6	2 days	Marquet MagdaDirector	PPurchase	+9.00K	$2.47	+$22.2K	+81.8%20.0K after
Sep 6, 2023 (view filing)	Sep 5	1 day	Marquet MagdaDirector	PPurchase	+10.0K	$2.47	+$24.7K	+1,000.0%11.0K after
Sep 5, 2023 (view filing)	Aug 31	5 days	Marquet MagdaDirector	PPurchase	+1.00K	$2.01	+$2.01K	New position1.00K after

ARCT Arcturus Therapeutics Holdings Inc.